Foveo Healthcare

Foveo Healthcare in Burbank, California offers Spravato (esketamine) for treatment-resistant depression, providing this FDA-approved nasal spray for adults who haven't responded to at least two prior antidepressants, as well as for major depressive disorder with suicidal ideation or behavior. Spravato is self-administered under healthcare supervision through the restricted Spravato REMS program and can be used with or without an oral antidepressant.

Working differently from traditional antidepressants by acting on the brain's glutamate system, esketamine offers an alternative path for patients with severe, persistent depression. Treatment begins with an evaluation to determine candidacy. The practice serves Burbank and the surrounding Los Angeles County communities.